Page last updated: 2024-08-24

aripiprazole and Autism Spectrum Disorder

aripiprazole has been researched along with Autism Spectrum Disorder in 47 studies

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's32 (68.09)24.3611
2020's15 (31.91)2.80

Authors

AuthorsStudies
Chen, MH; Escobar Liquitay, CM; Fieiras, C; Franco, JVA; Madrid, E; Meza, N; Rojas, V1
Bateman, BT; Gray, KJ; Hernández-Díaz, S; Huybrechts, KF; Lester, B; McDougle, CJ; Mogun, H; Pennell, PB; Straub, L; Suarez, EA; Wisner, KL; Zakoul, H; Zhu, Y1
Arango, C; Cabras, A; Cortese, S; Fusar-Poli, P; Hernández, P; Moreno, C; Parellada, M; Pastor Jordá, C; Salazar de Pablo, G; Santosh, P; Simonoff, E; Vaquerizo-Serrano, J; Veenstra-VanderWeele, J1
Choo, H; Jeon, B; Lee, A1
Campos, AC; Costa, KCM; Crippa, ACS; Crippa, JAS; Del-Bel, EA; Ferreira, FR; Guimarães, FS; Hallak, JEC; Lima, DA; Pedrazzi, JFC; Silva-Amaral, D; Zuardi, AW1
Alamiri, B; Hasan, AE; Jamali, MA; Naguy, A; Pridmore, S1
de Andrade, GM; de Barros Viana, GS; de Oliveira Ferreira, E; Lima, FAV; Neves, KRT; Pessoa Gomes, JM1
Aboul-Fotouh, S; El-Salam, MFA; Elayat, WM; Elhossiny, RM; Habib, MZ; Hassan, GAM; Mohamad, MI; Zohny, SM1
Bastiaansen, D; de Kroon, MMJ; de Winter, BCM; Dierckx, B; Hermans, RA; Hillegers, MHJ; Kloosterboer, SM; Koch, BCP; Kouijzer, MEJ; Nasserinejad, K; Reichart, CG; Sassen, SDT; van Altena, D; van Schaik, RHN1
Alaqel, SI; Algarni, MA; Alharbi, A; Almalki, AH; Almrasy, AA; Alqahtani, AS; Althobaiti, YS; Bamaga, AK1
Garel, N; Joober, R1
Albarwary, S; Butler, TA; Mustapha, MT; Ozsahin, DU; Ozsahin, I; Sanlidag, B1
Capizzi, M; Gliubizzi, C; Guccione, F; Mangano, S; Marino, A; Nardello, R1
Aoki, K; Fukuta, Y; Mikami, K; Sugimoto, Y; Takayama, T; Tomoda, A; Yamamura, K1
de Vries, F; Houghton, R; Law, K; Liu, Y; van den Bergh, J1
Katsuno, M; Kimura, S; Kuru, S; Minamiyama, M; Murakami, A; Noda, S1
Arnold, LE; Han, JC; Hellings, JA1
de Leon, J; Loveland, JG; McGrane, IR1
Binici, NC; Güney, SA1
Ago, Y; Hara, Y; Hasebe, S; Hashimoto, H; Kawase, H; Matsuda, T; Nakazawa, T; Takuma, K; Tanabe, W; Taruta, A; Tsukada, S1
Naguy, A1
Hiratani, M; Ichikawa, H; Ono, H; Oshimo, T; Tadori, Y; Tsujii, N; Yasuhara, A1
Anagnostou, E1
Akbas, B; Akca, OF1
Pringsheim, T; Shafiq, S1
Erickson, CA; Lamy, M1
Boustany, RM; Khalifeh, S; Kourtian, S; Yassin, W1
Araba, B; Marraffa, C1
Beex-Oosterhuis, MM; Dieleman, HG; Eussen, MLJM; Schoemakers, RJ; van Kesteren, C; van Rosmalen, J1
Bennett, TA; Beyene, J; Fallah, MS; Neupane, B; Rusiecki, D; Shaikh, MR1
Abramson, RK; Bradley, C; Bragg, JE; Carpenter, LA; Charles, JM; DeVane, CL; Donovan, JL; Geesey, ME; Gwynette, F; Hall, AG; Kinsman, A; Kruesi, MJ; Powers, NR; Raven, S; Sherk, ST; Spratt, E; Stuck, CA; Williams, JE1
Aguglia, E; Arillotta, D; Brondino, N; Damiani, S; Fusar-Poli, L; Petrosino, B; Petrosino, C; Politi, P; Provenzani, U; Rocchetti, M1
Bartram, LA; Coury, DL; Lozano, J1
Bayram, Ö; Hergüner, S; Hoşoğlu, E1
Percinel, I; Yazici, KU1
Erdogan, A; Gunes, H; Tanidir, C1
Hergüner, A; Hergüner, S1
Bacanli, A1
Accordino, RE; Henry, CA; Kidd, C; McDougle, CJ; Politte, LC1
Bernal, P; Coury, D; Fung, LK; Hardan, AY; Jo, B; Krasner, A; Mahajan, R; Nozzolillo, A; Veenstra-Vanderweele, J; Whitaker, A1
Açıkel, B; Hergüner, S; Yar, A1
Alosi, N; Cucinotta, F; Di Rosa, G; Gagliano, A; Germanò, E; Italiano, D; Lamberti, M; Siracusano, R; Spina, E1
Pavone, P; Rizzo, R1
Bruhn, CH; Fink-Jensen, A; Jakobsen, KD; Nielsen, J; Pagsberg, AK1
DeFilippis, M; Wagner, KD1
Ichikawa, H; Ishizaki, Y; Mikami, K; Okada, T; Ono, H; Tadori, Y; Tomoda, A; Usuki, C; Yamashita, Y1
Sanchack, KE; Thomas, CA1

Reviews

17 review(s) available for aripiprazole and Autism Spectrum Disorder

ArticleYear
Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews.
    BMJ evidence-based medicine, 2023, Volume: 28, Issue:1

    Topics: Aripiprazole; Autism Spectrum Disorder; Child; Humans; Risperidone; Systematic Reviews as Topic

2023
Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort Study.
    JAMA internal medicine, 2022, 05-01, Volume: 182, Issue:5

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Birth Cohort; Cohort Studies; Female; Humans; Male; Neurodevelopmental Disorders; Pregnancy

2022
Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2023, Volume: 62, Issue:2

    Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Humans; Risperidone

2023
Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment.
    International journal of molecular sciences, 2022, Jun-10, Volume: 23, Issue:12

    Topics: Aripiprazole; Autism Spectrum Disorder; Child; Humans; Receptors, Serotonin; Risperidone; Serotonin

2022
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
    Psychopharmacology, 2022, Volume: 239, Issue:9

    Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Cannabidiol; Child, Preschool; Endocannabinoids; Humans

2022
Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
    Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:6

    Topics: Adolescent; Adult; Amitriptyline; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Brain-Derived Neurotrophic Factor; Child; Dopamine Antagonists; Humans; Irritable Mood; Loxapine; Risperidone

2017
Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
    Current opinion in neurology, 2018, Volume: 31, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Depressants; Central Nervous System Stimulants; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Irritable Mood; Melatonin; Metformin; Methylphenidate; Obesity; Outcome Assessment, Health Care; Precision Medicine; Risperidone; Sleep; Sleep Wake Disorders

2018
Using antipsychotics for behavioral problems in children.
    Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:13

    Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Autism Spectrum Disorder; Child; Humans; Irritable Mood; Randomized Controlled Trials as Topic; Risperidone

2018
Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
    Current problems in pediatric and adolescent health care, 2018, Volume: 48, Issue:10

    Topics: Adolescent; Aripiprazole; Autism Spectrum Disorder; Child; Comorbidity; Guidelines as Topic; Humans; Irritable Mood; Mental Disorders; Psychotropic Drugs; Randomized Controlled Trials as Topic; Risperidone

2018
AUTISM IN REVIEW.
    Le Journal medical libanais. The Lebanese medical journal, 2016, Volume: 64, Issue:2

    Topics: Aripiprazole; Autism Spectrum Disorder; Central Nervous System Agents; Diagnostic and Statistical Manual of Mental Disorders; Diffusion Tensor Imaging; Fluoxetine; Humans; Risk Factors; Risperidone; White Matter

2016
Short-term aripiprazole therapy for autism spectrum disorder.
    Journal of paediatrics and child health, 2018, Volume: 54, Issue:12

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Humans; Treatment Outcome

2018
Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.
    Journal of child and adolescent psychopharmacology, 2019, Volume: 29, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Checklist; Child; Humans; Irritable Mood; Network Meta-Analysis; Randomized Controlled Trials as Topic; Risperidone

2019
Aripiprazole for treating irritability associated with autism spectrum disorders.
    Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:12

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Communication; Humans; Irritable Mood; Mood Disorders; Treatment Outcome

2019
Psychopharmacological interventions in autism spectrum disorder.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:7

    Topics: Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Humans; Irritable Mood; Psychotropic Drugs; Risperidone; Stereotyped Behavior

2016
Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
    Pediatrics, 2016, Volume: 137 Suppl 2

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Humans; Irritable Mood; Problem Behavior; Risperidone; Self-Injurious Behavior

2016
Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders.
    Expert review of neurotherapeutics, 2016, Volume: 16, Issue:8

    Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Humans; Irritable Mood; Prospective Studies

2016
Autism Spectrum Disorder: Primary Care Principles.
    American family physician, 2016, Dec-15, Volume: 94, Issue:12

    Topics: Antipsychotic Agents; Aripiprazole; Asperger Syndrome; Autism Spectrum Disorder; Autistic Disorder; Behavior Therapy; Child Development Disorders, Pervasive; Child, Preschool; Early Diagnosis; Early Medical Intervention; Humans; Infant; Primary Health Care; Referral and Consultation; Risperidone

2016

Trials

3 trial(s) available for aripiprazole and Autism Spectrum Disorder

ArticleYear
Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
    Pharmacotherapy, 2019, Volume: 39, Issue:6

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Double-Blind Method; Female; Humans; Male; Risperidone; Treatment Outcome; Weight Gain

2019
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.
    Paediatric drugs, 2016, Volume: 18, Issue:4

    Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Female; Humans; Male; Pilot Projects; Risperidone

2016
Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study.
    Child psychiatry and human development, 2017, Volume: 48, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Double-Blind Method; Female; Humans; Irritable Mood; Japan; Male; Parents; Treatment Outcome

2017

Other Studies

27 other study(ies) available for aripiprazole and Autism Spectrum Disorder

ArticleYear
Agomelatine Monotherapy for Autism-A Case Report.
    Psychopharmacology bulletin, 2022, 10-27, Volume: 52, Issue:4

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Humans; Risperidone

2022
Maternal treatment with aripiprazole prevents the development of a valproic acid-induced autism-like phenotype in juvenile male mice.
    Behavioural pharmacology, 2023, 04-01, Volume: 34, Issue:2-3

    Topics: Animals; Anticonvulsants; Aripiprazole; Autism Spectrum Disorder; Behavior, Animal; Disease Models, Animal; Female; Male; Mice; Phenotype; Pregnancy; Prenatal Exposure Delayed Effects; Seizures; Social Behavior; Valproic Acid

2023
Memantine/Aripiprazole Combination Alleviates Cognitive Dysfunction in Valproic Acid Rat Model of Autism: Hippocampal CREB/BDNF Signaling and Glutamate Homeostasis.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2023, Volume: 20, Issue:2

    Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Glutamates; Hippocampus; Homeostasis; Male; Memantine; Pregnancy; Rats; Rats, Wistar; Valproic Acid

2023
Towards precision dosing of aripiprazole in children and adolescents with autism spectrum disorder: Linking blood levels to weight gain and effectiveness.
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:10

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Body Mass Index; Child; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Weight Gain

2023
Spectrofluorometric quantitative analysis of aripiprazole based on quenching of natural derived carbon quantum dots in spiked human plasma.
    Scientific reports, 2023, Nov-29, Volume: 13, Issue:1

    Topics: Aripiprazole; Autism Spectrum Disorder; Carbon; Child; Humans; Quantum Dots; Spectrometry, Fluorescence

2023
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency
    Journal of psychiatry & neuroscience : JPN, 2019, Nov-01, Volume: 44, Issue:6

    Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Delusions; Dystonia; Female; Hallucinations; Humans; Hypnotics and Sedatives; Intellectual Disability; Lorazepam; Loxapine; Olanzapine; Paranoid Disorders; Psychotic Disorders; Quetiapine Fumarate; Tourette Syndrome

2019
An investigation to choose the proper therapy technique in the management of autism spectrum disorder.
    Journal of comparative effectiveness research, 2021, Volume: 10, Issue:5

    Topics: Aripiprazole; Autism Spectrum Disorder; Fuzzy Logic; Humans; Risperidone

2021
Resolution of enuresis with aripiprazole in children with psychiatric disorders: two case reports.
    Journal of medical case reports, 2021, Apr-21, Volume: 15, Issue:1

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Female; Humans; Male; Nocturnal Enuresis; Schizophrenia

2021
Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance.
    BMC psychiatry, 2021, 04-22, Volume: 21, Issue:1

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Humans; Irritable Mood; Japan; Marketing; Product Surveillance, Postmarketing; Prospective Studies; Treatment Outcome

2021
Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disorders.
    Autism research : official journal of the International Society for Autism Research, 2021, Volume: 14, Issue:8

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Cohort Studies; Female; Fractures, Bone; Humans; Male; Retrospective Studies; Risperidone; United States

2021
Duchenne Muscular Dystrophy Successfully Treated with Aripiprazole in a Patient with Autism Spectrum Disorder Symptoms Including Irritability.
    Internal medicine (Tokyo, Japan), 2021, Dec-15, Volume: 60, Issue:24

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Humans; Irritable Mood; Male; Muscular Dystrophy, Duchenne

2021
Possible Oxcarbazepine Inductive Effects on Aripiprazole Metabolism: A Case Report.
    Journal of pharmacy practice, 2018, Volume: 31, Issue:3

    Topics: Anticonvulsants; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Carbamazepine; Child; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Male; Oxcarbazepine; Treatment Outcome

2018
Epistaxis as an Unexpected Side Effect of Aripiprazole and Risperidone Treatment in Two Children with Two Different Psychiatric Diagnosis.
    Journal of child and adolescent psychopharmacology, 2017, Volume: 27, Issue:8

    Topics: Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Epistaxis; Humans; Male; Mood Disorders; Risperidone

2017
Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
    Psychopharmacology, 2017, Volume: 234, Issue:21

    Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Dendritic Spines; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Female; Haloperidol; Male; Mice; Mice, Inbred ICR; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Risperidone; Social Behavior; Valproic Acid

2017
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
    The Journal of nervous and mental disease, 2017, Volume: 205, Issue:9

    Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Comorbidity; Cross-Sectional Studies; Guanfacine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risperidone; Social Adjustment; Treatment Outcome

2017
An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan.
    Psychiatry and clinical neurosciences, 2018, Volume: 72, Issue:2

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Female; Humans; Irritable Mood; Japan; Male; Outcome Assessment, Health Care

2018
Treatment of a Child with Autism Spectrum Disorder and Food Refusal Due to Restricted and Repetitive Behaviors.
    Journal of child and adolescent psychopharmacology, 2018, Volume: 28, Issue:5

    Topics: Aggression; Aripiprazole; Autism Spectrum Disorder; Child; Feeding and Eating Disorders; Humans; Male; Mirtazapine; Problem Behavior

2018
No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months.
    Journal of child and adolescent psychopharmacology, 2019, Volume: 29, Issue:3

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Body Mass Index; Child; Female; Humans; Male; Netherlands; Psychotic Disorders; Retrospective Studies; Risperidone; Time Factors; Weight Gain

2019
Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study.
    Psychiatry research, 2019, Volume: 276

    Topics: Adolescent; Adult; Aripiprazole; Autism Spectrum Disorder; Benzodiazepines; Child; Comorbidity; Cross-Sectional Studies; Drug Prescriptions; Female; Humans; Irritable Mood; Italy; Male; Middle Aged; Practice Patterns, Physicians'; Prevalence; Psychotropic Drugs; Risperidone; Young Adult

2019
Nasal and Gingival Bleeding During Aripiprazole but not Haloperidol Treatment.
    Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:10

    Topics: Aripiprazole; Autism Spectrum Disorder; Child; Epistaxis; Gingival Hemorrhage; Haloperidol; Humans; Male

2016
The Use of Aripiprazole in Young Children with Autism Spectrum Disorders: The Treatment and 16 Week Follow-Up of a 23-Month-old Male Patient.
    Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:9

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child, Preschool; Follow-Up Studies; Humans; Infant; Male; Quinolones; Treatment Outcome

2016
Effective Use of Aripiprazole Augmentation in a Clozapine-Treated Adolescent with Autism Spectrum Disorder.
    Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:9

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Clozapine; Drug Therapy, Combination; Humans; Male

2015
Pica in an Adolescent with Autism Spectrum Disorder Responsive to Aripiprazole.
    Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:1

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Female; Humans; Pica

2016
Aripiprazole Use in Children Diagnosed with Down Syndrome and Comorbid Autism Spectrum Disorders.
    Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Comorbidity; Down Syndrome; Humans; Male; Turkey

2016
Functional Vomiting Treated Successfully with Aripiprazole in a Child with Autism Spectrum Disorder.
    Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:2

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Humans; Male; Treatment Outcome; Vomiting

2016
Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
    Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Databases, Factual; Denmark; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Neurodevelopmental Disorders; Obsessive-Compulsive Disorder; Psychotic Disorders; Schizophrenia; Tourette Syndrome

2016
Treatment of Autism Spectrum Disorder in Children and Adolescents.
    Psychopharmacology bulletin, 2016, Aug-15, Volume: 46, Issue:2

    Topics: Adolescent; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Child; Humans; Irritable Mood; Risperidone; Serotonin Antagonists

2016